Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Cirrus Logic, Inc.(NASDAQ:CRUS), InterMune Inc(NASDAQ:ITMN), TAL International Group, Inc.(NYSE:TAL), Raptor Pharmaceutical Corp.(NASDAQ:RPTP)
Cirrus Logic, Inc.(NASDAQ:CRUS) was a volume gainer of 2.34 million shares and the average volume of the stock remained 1.71 million shares. The stock opened the session at $19.71 and finished at the end of the day at $19.04 and the stock plunged -2.86%.The market capitalization of the stock remained 1.21 billion. Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets. Cirrus Logic, Inc. sells its products through direct sales force, external sales representatives, and distributors. The company was founded in 1984 and is headquartered in Austin, Texas.
Has CRUS Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, InterMune Inc(NASDAQ:ITMN) exchanged 2.33 million shares and the average volume remained 853,978.00 shares. The stock closed the session at $16.57 with the gain of 9.52%. InterMune, Inc., a biotechnology company, engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases. The company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.
Will ITMN Continue To Move Higher? Find Out Here
TAL International Group, Inc.(NYSE:TAL) decreased -4.67% and its closing price was $46.96. The volume of the stock was 2.32 million shares and the average volume remained 491,120.00 shares. The market capitalization of the stock remained 1.59 billion. The beta of the stock remained 1.78. TAL International Group, Inc. engages in leasing intermodal containers and chassis worldwide. The company operates in two segments, Equipment Leasing and Equipment Trading. TAL International Group, Inc. was founded in 1963 and is headquartered in Purchase, New York.
Will TAL Get Buyers Even After The Recent Rally? Find Out Here
Raptor Pharmaceutical Corp.(NASDAQ:RPTP) exchanged 2.24 million shares in the previous trading session, and its average trading remained 604,897.00 shares. RPTP advanced 6.46% and it closed the trading at $14.51. The market capitalization of the stock remained 889.34 million. Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. It engages in the research, manufacture, and commercialization of medicines to treat nephropathic cystinosis, non-alcoholic steatohepatitis (NASH), Huntington's disease (HD), and aldehyde dehydrogenase deficiency (ALDH2).
For How Long RPTP’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)